Processing

Please wait...

Settings

Settings

1. WO2002076933 - FORMAILIDE DERIVATIVES AS BETA2-ADRENORECEPTOR AGONISTS

Publication Number WO/2002/076933
Publication Date 03.10.2002
International Application No. PCT/EP2002/003122
International Filing Date 20.03.2002
Chapter 2 Demand Filed 14.10.2002
IPC
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
311
Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
22
Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
29
having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
C07C 311/29 (2006.01)
CPC
C07C 311/29
Applicants
  • GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN, GB (AllExceptUS)
  • BIGGADIKE, Keith [GB/GB]; GB (UsOnly)
  • FIELD, Rita [GB/GB]; GB (UsOnly)
  • GUNTRIP, Stephen, Barry [GB/GB]; GB (UsOnly)
  • LOOKER BRIAN, Edgar [GB/GB]; GB (UsOnly)
Inventors
  • BIGGADIKE, Keith; GB
  • FIELD, Rita; GB
  • GUNTRIP, Stephen, Barry; GB
  • LOOKER BRIAN, Edgar; GB
Agents
  • FLORENCE, Julia, Anne; Corporate Intellectual Property GlaxoSmithKline 980 Great West Road (CN925.1) Brentford Middlesex TW8 9GS, GB
  • WALKER, Ralph, Francis; GlaxoSmithKline Corporate Intellectual Property CN925.1 980 Great West Road Brentford, Middlesex TW8 9GS, GB
Priority Data
0107213.122.03.2001GB
0126995.009.11.2001GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) FORMAILIDE DERIVATIVES AS BETA2-ADRENORECEPTOR AGONISTS
(FR) DERIVES FORMANILIDES UTILISES EN TANT QU'AGONISTES DE L'ADRENORECEPTEUR BETA2
Abstract
(EN)
The present invention relates to novel compounds of formula (I), to a process for their menufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
(FR)
L'invention se rapporte à de nouveaux composés représentés par la formule (I), à un procédé de fabrication, à des compositions pharmaceutiques les contenant et à leur utilisation thérapeutique, plus précisément à leur utilisation dans la prophylaxie et le traitement des maladies respiratoires.
Latest bibliographic data on file with the International Bureau